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Abstract
Recently emerged fungal diseases, Batrachochytrium dendrobatidis (Bd) and Batrachochy-
trium salamandrivorans (Bsal) are an increasing threat to amphibians worldwide. In Europe,
the threat of Bsal to salamander populations is demonstrated by the rapid decline of fire sal-
amander populations in Germany, the Netherlands and Belgium. Although most European
urodelans are susceptible to infection in infection trials, recent evidence suggests marked
interspecific differences in the course of infection, with potentially far reaching implications
for salamander conservation. As a salamander’s skin is the first line of defense against such
pathogens, interspecific differences in innate immune function of the skin may explain differ-
ential susceptibility. Here we investigate if compounds present on a salamander’s skin can
kill Bsal spores and if there is variation among species. We used a non-invasive assay to
compare killing ability of salamander mucosomes of four different species (captive and wild
Salamandra salamandra and captive Ichtyosaura alpestris, Cynops pyrrhogaster and Lisso-
triton helveticus) by exposing Bsal zoospores to salamander mucosomes and determining
spore survival. In all samples, zoospores were killed when exposed to mucosomes. More-
over, we saw a significant variation in this Bsal killing ability of mucosomes between different
salamander host species. Our results indicate that mucosomes of salamanders might pro-
vide crucial skin protection against Bsal, and could explain why some species are more sus-
ceptible than others. This study represents a step towards better understanding host
species variation in innate immune function and disease susceptibility in amphibians.
Introduction
Wildlife diseases are an increasing threat to biodiversity [1,2]. Over the last two decades
amphibian populations have declined due to recently emerged diseases [3–5]. Among them,
fungal pathogens, such as Batrachochytrium dendrobatidis (hereafter Bd) and
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Batrachochytrium salamandrivorans (hereafter Bsal), etiological agents of chytridiomycosis
have been wreaking havoc on amphibian populations worldwide [6–12]. In Europe, Bsal
emerged suddenly and severely, causing a population of fire salamanders to nearly collapse in
the Netherlands, with less than 0.1% of the population remaining [13,14]. Similar population
collapses occurred in Belgium [15] and have been found in Germany [16]. Probably originat-
ing in Asia [17,18] this pathogen may have a quick and devastating effect on most salamander
species of Europe. The risk of further spread globally has caused proactive responses in the
form of taskforces to emerge and trade restrictions to be implemented in the USA, Canada
and Switzerland [19,20].
Batrachochytrium salamandrivorans differs from its sister species (Bd) in that the disease is
limited to urodelans but, like Bd, the effect it has on its host differs greatly among but also
within species [15,17,21]. Previous infection trial studies observed a range of host susceptibil-
ity, from highly susceptible (ie. fire salamanders Salamandra salamandra) to moderately sus-
ceptible (ie. alpine newt Ichtyosaura alpestris and Japanese fire belly newt Cynops pyrrhogaster)
to resistant (ie. palmate newt Lissotrition helveticus) [15]. The differences seen in disease sus-
ceptibility could be partly the result of immune defenses, as these are known to vary among
individuals and species [22]. In addition to host immune factors, susceptibility of amphibians
to Bd has been attributed to many different factors including skin microbiota [23–25], genetic
makeup of populations [26] and environmental factors [27,28].
Given the increasing threat of new pathogens to amphibians, understanding host immune
function and susceptibility is increasingly important [22]. In amphibians, the first line of
defense against chytrid pathogens is their skin [29]. As amphibians use their skin for a multi-
tude of key physiological functions (e.g. chemical defenses, thermo- and osmoregulation) their
skin is a particularly important organ, vulnerable to invading pathogens [30]. Bd and Bsal tar-
get and invade the amphibian’s skin, thereby interfering with the skin’s vital functions [31,32].
Therefore, understanding innate immune factors present on the skin of amphibians, and how
this immune function varies between individuals and species is important.
Amphibian skin generally has two types of specialized secretory glands which help protect
the skin. Firstly, granular glands produce defensive secretions that contain a cocktail of differ-
ent bioactive molecules (i.e. alkaloids, TTX toxins, steroids, amines, antibodies, lysozymes and
antimicrobial peptides) [29, 33–39]. The exact molecules vary widely among amphibians and
are used for predator deterrence and host immunity. In many amphibian species, these glands
are concentrated in large conspicuous structures [40] that release their poisonous content
upon irritation, mechanical pressure, stress or adrenaline stimulation [41]. Besides releasing
bioactive components when stimulated, studies have shown that the granular glands of non-
stressed frogs also release such components into the mucous layer at low levels [42]. Secondly,
mucous glands produce a mixture of mucin glycoproteins that make up the main component
of the skin mucosal layer and can behave as a physical barrier to pathogenesis [29]. Addition-
ally, the skin and mucous layer have been shown to harbor a community of microbiota (and
their metabolites), believed to influence growth of pathogens [43–45]. Together the mixture of
mucin glycoproteins, granular gland secretions [46] and the skin microbiota make up the
mucosome [46,47].
Research on amphibian skin immune function focuses largely on frog species and the effect
of AMPs which have been shown to reduce infection loads of Bd, in some cases allowing the
animal to clear the infection [29,42,48–51]. The long history of research in skin secretions of
salamanders has revealed a plethora of defensive compounds [52–54]. Within Salamandridae,
several species produce alkaloids, namely samandarine and samandarone [34,37,55,56] and
TTX toxins in their secretions [36,38,39]. However, comparatively few studies have shown the
effect of salamander skin secretions against Bd, with a few exceptions [57–60]. Here we
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investigate whether salamander mucosomes and skin secretions can affect Bsal and/or Bd
spore viability using the vulnerable fire salamander as our main model. Additionally, we exam-
ined whether the innate immune function of the salamander’s mucosome differs among host
species in its killing ability of Bsal.
Materials & methods
Study animals and husbandry
To determine the extent to which fire salamander skin secretions and fire salamander, alpine
newt, palmate newt and Japanese fire belly newt mucosomes are capable of killing Bsal zoo-
spores, we sampled mucosomes from captive born and raised animals. All animals used were
adults and randomly selected from their terraria or tanks. Fire salamanders, alpine newts and
palmate newts were selected as they are all European species co-occurring in Bsal infected for-
ests and have differing susceptibilities during infection trails. The Japanese fire belly newt was
included as an Asian species suspected of being a Bsal carrier. Fire salamanders were housed
in large mesocosms of 2.5 m by 1.25 m in groups of 10–15 animals with moist soil and dry
leaves and clay tiles for shelter and kept at 8˚C—15˚C. Palmate newts, alpine newts and Japa-
nese fire belly newts were housed separately in large glass tanks of 40 cm by 60 cm in groups of
10, on moist soil and dry leaves with clay tiles for shelter and kept between 15˚C—20˚C. For
all animals, appropriate food (crickets, worms or bloodworms) was provided ad libitum. In
addition, mucosomes of fifteen wild fire salamander were collected in November 2016 from
Makegem- Harentbeek forest East Flanders, Belgium. A 54.24 ha private forest with 10 ponds
(latitude 50.945331, longitude 3.714886). Animal experiments were conducted according to
biosecurity and ethical guidelines set forth by the ethical committee of the Faculty of Veteri-
nary Medicine, Ghent University. Ethical permission was not required under Belgian Legisla-
tion (Law 14 August 1986 related to the protection of animals). Permits for sampling of wild
fire salamanders were granted by Agentschap voor Natuur en Bos of East Flanders in Belgium,
license number ANB/BL/FF-V15-00015.
Experimental procedure
Mucosome bathing was performed on all salamanders and newts as described in Woodhams
et al. 2014 [46]. Each amphibian was rinsed prior to bathing, and its surface area was calculated
according to Spight et al. 1968 (surface area in cm2 = 8.42(mass in g)^(0.694) and divide sur-
face area by 4 to determine quantity of water to add)[61]. Animals were bathed in HPLC water
for 1 hour and the wash solution was collected and frozen at -20˚C until further analysis.
Fire salamander skin secretions were collected by massaging the granular glands with a
microbiological inoculation loop rubbed over the dorsal tail. Collected skin secretions where
weighed to the nearest 0.1 mg. Varying amount of skin secretions where collected per individ-
ual, ranging from 5 mg to 20 mg. To create a skin secretions suspension HPLC water was
added to the sample at a ratio of 10 μl of water to 1 mg of secretions. The samples were then
sonicated in a sonication bath (Branson 2510 ultrasonication bath) for 15 mins (120V, 60Hz).
Samples were frozen at -20˚C until analysis.
We performed experiments in which we exposed Bd JEL 423 and Bsal AMFP 13/01 zoo-
spores (106 per mL) to the mucosome bathing solution or skin secretions (Palmate newt/Japa-
nese fire belly newt n = 6, captive fire salamander/alpine newt n = 8, wild fire salamander
n = 15). Bd JEL 423 and Bsal AMFP 13/01 cultures were grown in flasks in TGhL (tryptone,
gelatin hydrolysate and lactose) broth at 20˚C and 15˚C respectively. During sporulation, zoo-
spores were harvested and filtered (filter size 10 μm) to remove sporangia. Spore concentration
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was determined by haemocytometer count using lugol solution (Sigma) to stain zoospores.
Zoospore suspensions of 1 x 106 mL were used for all assays.
We used trypan blue staining to determine viability of Bd and Bsal spores after exposure to
amphibian mucosomes or glandular gland skin secretions. The protocol was adapted from
McMahon and Rohr 2014 [62].
The Bd or Bsal survival assays were performed by adding zoospore suspension to muco-
some and skin secretion solution and incubating for 60 minutes. The number of viable Bd or
Bsal zoospores in the zoospore suspension was determined before inoculation. HPLC water
(treated as wash solution without the salamander) was used to provide a background surviv-
ability of Bd or Bsal spores, heat-killed spores were used as positive control. After incubation,
the numbers of remaining viable zoospores were calculated using trypan blue dye (0.4% trypan
blue in phosphate buffered saline). Viable spores were counted using a hemocytometer and
compound microscope. All tests were performed blind and repeated in triplicate. Secretion
samples were completely sterilized by one hour of UV radiation to eliminate possible effects of
live bacteria in our experiments. Mucosome solutions were sterilized using 0.2 μm filters.
We calculate the killing ability of each animal’s skin defenses by comparing the (mean) via-
ble chytrid spores after inoculation with mucosome (or secretions) versus the negative control
(viable spores in water) to calculate the percent viable spores.
Skin defenses components
To investigate the components responsible for the observed Bsal killing ability, we collected
skin secretions of fire salamanders and mucosomes of alpine newts as described above, the lat-
ter were used as their mucosomes exhibited marked zoospore killing activity.
In order to investigate whether the bioactive compounds are large (high molecular weight)
or small (low molecular weight) molecules, we separated components based on size using dial-
ysis with different membrane pore sizes. Dialysis membranes (Spectra/Por Micro Float-A-
Lyzer and Specta/Por 6 Dialysis Tubing), size 50 kD were used per the manufacturer’s instruc-
tions. Samples were loaded into the filter and spun for 16 hours at 4˚C to remove smaller parti-
cles. The samples were then used to run the Bsal spore viability assay.
To test whether the active components could be proteins or peptides we denatured all pro-
teins and peptides present in the secretions and mucosomes using Endoproteinase GluC (Sta-
phylocococcus aureus Protease V8, New England BioLabs), according to the manufacturer’s
instructions. Digestion of proteins/peptides was achieved by adding GluC Reaction Buffer to
sample and Endoproteinase GluC for 16 hours at 37˚C. The samples were then used to run the
Bsal spore viability assay.
To examine the proteins present in fire salamander skin secretions (diluted 1:100) we per-
formed SDS-PAGE (Sodium dodecyl sulfate polyacrylamide gel electrophoresis) Mini-Protean
3 Cell gel (Bio-Rad) with Brilliant blue G-Colloidal concentrate staining used by manufactures
specifications (Sigma).
Mass spectrometry
Further examination of fire salamander skin secretion proteins was done by in-gel digestion
followed by high resolution LCMSMS analysis (Synapt G2Si, Waters) using HDDDA acquisi-
tion. Data was searched using an in-house Mascot Server against a Uniprot Amphibia library.
Statistical analysis
All analyses were performed in SPSS version 24, and all data were checked for normality and
equality of variance among groups prior to statistical analysis. A Student’s t-test (normal
Salamander skin mucosome effect on Bsal
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distribution) or Mann Whitney U test (non-normal distribution) was performed to examine
the difference in viable Bd and Bsal spores after inoculation with the fire salamander muco-
some and secretion. To test whether the mucosome killing-ability varies among species, we
performed a one-way analysis of variance (ANOVA) followed by a Tukey (equal variances
assumed) or Games-Howell (equal variances not assumed) post hoc test.
Results
Skin defenses function
Fire salamander skin secretions were shown to drastically reduce viable spores of Bsal and Bd,
resulting in more than 80% spore mortality after one hour in both chytrid species (Fig 1A).
Bsal and Bd spore mortality were not significantly different with 92.5% and 90.5%, respectively
(U = 32, p = 1.00). The mucosome of fire salamanders killed a substantial amount of chytrid
spores (Fig 1B), however, reduction in viable Bd spores (54.5%) was significantly greater than
Bsal spores (26.5%) (t = 4.4, df = 11 p = 0.001). The killing ability of salamander secretions on
both chytrid species was markedly higher than salamander mucosome solutions (compare Fig
1A to 1B).
Bsal spore mortality varied significantly between the mucosomes of the four different sala-
mander species (ANOVA: F = 35.032, df = 3, 24, p< 0.001) (Fig 2). The only two mucosomes
that did not differ significantly in their Bsal killing activity were those of the alpine newts and
palmate newt (p = 0.998). These two species’ mucosomes killed a significant portion of Bsal
spores, with 77.6% and 78.9% spore mortality respectively. Captive fire salamander muco-
somes killed the fewest spores with an average 20.7% spore mortality, while fire belly newts
killed a higher percentage of spores (average of 45% spore mortality). These results correlate
with the known susceptibility of these species when infected with Bsal during clinical trials
[15,17]. To check if mucosome activity of captive fire salamanders is similar to that of wild fire
salamanders, we tested the mucosome activity of 15 wild fire salamanders against Bsal zoo-
spores. This resulted in an average Bsal spore mortality of 28.8%, which is comparable to cap-
tive fire salamanders mucosomes (Fig 2). Wild fire salamanders displayed a slightly larger
variation in Bsal killing ability, ranging between 0 to 63 percent spore mortality, compared to
2 to 40 percent in captive animals.
Protein analysis
Protein denaturation of fire salamander skin secretions resulted in a decrease in Bsal killing-
ability, with a major decrease in spore mortality of 39.1% compared to the control treatment
(Fig 3A). When samples were filtered with a 50 kD dialysis membrane (to remove smaller mol-
ecules), we didn’t observe an apparent reduction in the killing activity of the secretions (Fig
3A). Similar effects were observed when testing the killing activity of alpine newt mucosomes
after protein denaturation and dialysis (compare Fig 3A to 3B).
The banding pattern on SDS-PAGE gel used to examine proteins from the secretions, rang-
ing in size from proteins at ~16 kD to ~250 kD. Prominent bands were seen at ~16 kD, ~70
kD, ~80 kD and ~250 kD. Proteins and peptides of a mass below 16 kD were not detected (S1
Fig).
Analysis of protein bands by LCMSMS resulted in tentative identification as mostly struc-
tural/cellular proteins. However, annotation results and further identification of candidate
immune/defence proteins were inconclusive due to poor proteome coverage of our target
species.
Salamander skin mucosome effect on Bsal
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Discussion
As the surface of the skin represents the first contact between the amphibian host and its chy-
trid pathogen, the innate immune function of the skin is a key first step influencing subsequent
disease dynamics. We found that components on urodelan skin can kill zoospores of both Bd
and Bsal. Moreover, Bsal killing activity of the mucosome of different salamander’s species
reflect their known susceptibility.
Focusing on skin defenses of fire salamanders, skin secretions were found to be surprisingly
effective in killing both Bd and Bsal spores with ten to hundred-fold dilutions of skin secretion
Fig 1. a) Fire salamander secretion killing activity versus Bd and Bsal zoospores. b) Fire salamander mucosome killing
activity versus Bd and Bsal zoospores. Secretions (diluted 1:10) and mucosome of fire salamander (n = 8). Shown are
the mean +/- SD of the percentage of viable zoospores observed after 60 minutes of incubation (compared with viable
spores exposed to water). Asterisks indicate a significant difference at p< 0.05.
https://doi.org/10.1371/journal.pone.0199295.g001
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samples killing the great majority of Bsal and Bd spores. On the contrary, mucosomes of both
captive and wild fire salamanders are less effective at killing Bsal spores. This apparent differ-
ence between mucosomes and granular gland secretions could be due to the fact that active
components originate from the secretions and are still present in the mucosome, but at a more
diluted concentration. High quantities of secretions are only produced during irritation,
mechanical pressure, stress or adrenaline stimulation [41,42]. Interestingly, fire salamander
mucosome activity against Bd and Bsal reflects the differences in their susceptibility to these
two chytrid species (Fig 1). Fire salamander are highly susceptible to Bsal, with 100% lethality
of fire salamanders during infection trials [17], and field reports show that its effects in the
wild are similarly lethal [14,15]. Conversely, Bd does not kill fire salamanders in clinical trials,
but published data on this is lacking due to the difficulty in establishing Bd infection in the
host. Furthermore, the only report of Bd having a lethal effect on fire salamanders originates
from the Peñalara Natural Park, Spain [63].
Palmate newts are apparently resistant to Bsal during infection trials [17] and there have
been no observations of wild palmate newts being infected even though these newts are found
within environments where Bsal is present. The mucosome of this species killed three-quarters
of Bsal spores in one hour. In addition to the highly susceptible fire salamander and the resis-
tant palmate newt we tested two moderately susceptible species, alpine newts and Japanese fire
belly newts. The effect of Bsal on alpine newts is dose-dependent. During infection trials with a
high dose of Bsal the animals become sick and die [17], whereas when the dose is lower ani-
mals can recover and clear the infection [15]. Although there are some reports of infected
alpine newts in the wild, prevalence is low (<10%) and no population declines have been
observed [16] even when co-occurring with infected fire salamanders. While other factors
could be at play, this suggests that a low infection dose of Bsal could possibly be more represen-
tative of natural disease dynamics.
Fig 2. Bsal zoospore survival after exposure to different species mucosomes. F.S. = fire salamander (n = 8), A.N. = alpine newt
(n = 8), F.B.N. = Japanese fire belly newt (n = 6), P.N. = palmate newt (n = 6). Wild F.S. are depicted for comparison but originated
from a separate experiment (n = 15). Shown are the mean +/- SD of the percentage of viable zoospores observed after 60 minutes of
incubation (compared with control, viable spores in water). F.S. vs A.N. (p< 0.001), F.S. vs F.B.N. (p = 0.011), F.S. vs P.N. (p< 0.001),
A.N. vs F. B. N. (p< 0.001), A.N. vs P. N. (p = 0.998).
https://doi.org/10.1371/journal.pone.0199295.g002
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We show that the alpine newt mucosome kills larger amount of Bsal spores than the fire sal-
amander, suggesting that the mucosomes aid the species in clearing the disease. We see a
marked similarity in the mucosome activity of the alpine newt and palmate newt, but not in
their susceptibilities. In infection trials Bsal has proven to be highly invasive in alpine newt
skin but not in the palmate newt [17,64], suggesting that for the palmate newt, the skin itself
could be playing a role in its susceptibility, in addition to the mucosome. The Japanese fire
belly newt is moderately susceptible to Bsal, at high infection doses around half infected
Fig 3. a) Bsal zoospore survival in the presence of treated and untreated fire salamander skin secretions. Pooled
secretions (diluted 1:100, n = 3) b) Bsal zoospore survival with treated and untreated alpine newt mucosomes. Pooled
mucosomes (n = 13). Shown are the mean +/- SD of the percentage of viable zoospores observed after 60 minutes of
incubation (compared with control, viable spores in water).
https://doi.org/10.1371/journal.pone.0199295.g003
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animals die and half recover [17]. Here we found that the mucosome kills roughly half of
exposed spores. Although it could be assumed that both the fire belly newt and the alpine newt
should have similar mucosome killing activity, the statistical discrepancy between the muco-
some function of these species can be explained. Firstly, by the large variation seen in alpine
newt mucosomes (Fig 2 versus Fig 3B), secondly, although the killing activity of Japanese fire
belly newts’ mucosomes might not be as great as those of alpine newts, its susceptibility status
could be due to more adaptive immune factors as a result of co-evolution with Bsal in Asia
[18].
Previous work investigating skin defenses of amphibians against Bd has focused largely on
frog species; their antimicrobial peptides [29,42,48–51] and their bacterial metabolites [65–
69]. There is however, a rapidly growing body of work on skin microbiota of salamanders [70–
72]. Furthermore, studies of Plethodon salamander skin bacterial metabolites have shown anti-
Bd activity [73–76]. But a lot of questions remain in regards to salamander skin immune com-
pounds, and their activity against the newly emerged Bsal.
Surprisingly, our data indicate that the active anti-chytrid molecules in both the secretions
and mucosomes are proteins. Elimination of bacteria from the samples and removal of the low
molecular weight fraction (small active molecules like bacterial metabolites) did not affect the
ability to kill the spores. This suggests that the main active compounds are not the commonly
studied bacterial metabolites, alkaloids or steroidal salamander toxins. Denaturing the protein
fraction in both skin secretions and mucosomes drastically reduced the Bsal killing ability,
which together with the prominent bands on the SDS-PAGE gel suggest the presence of one or
several bioactive proteins. Mass spectrometry revealed the presence of proteins but unfortu-
nately, identification of candidate bioactive proteins by LCMSMS mass spectrometry in the
skin secretions was unsuccessful due to poor proteomic coverage of our model species. How-
ever, several antimicrobial and cytotoxic proteins (in the range of 6 to 72 kDa) like bactericidal
proteins, lysozymes, lectins, protease inhibitors and βγ-crystallins have been characterized in
the skin secretions of a wide range of frog species [77–80] and analogous compounds may be
present in the understudied secretions of urodelans. Future studies using a combination of
transcriptomics (e.g. RNAseq of the skin), proteomics and genomics could help identify candi-
date immune compounds, and thereby broaden our knowledge on salamander innate
immunity.
In our case, fire salamander mucosome function mirrors the susceptibility of Bd and Bsal
reported from wild animals and experimental data more accurately than the salamander’s
secretions. This is further exemplified by the congruence between the mucosome activity and
Bsal susceptibility of our other tested salamander species. Although increased secretion of
granular gland contents is well known in a state of acute stress (e.g. during a predator threat)
[42,52,53], evidence for increased secretion during the initial state of infection remains scarce
and inconclusive. It seems logical to study constitutive skin defenses, particularly as the muco-
some of amphibians has been shown to contain many factors that can affect chytrid viability.
Although the study of skin secretions has proven its immense value for understanding
amphibian immunity and skin defenses, our case shows that incorporating mucosome data
can result in a more holistic view when studying host susceptibility.
The fact that mucosome activity of captive and wild fire salamanders is highly comparable,
indicates that our data obtained from captive animals is biologically relevant, mirroring the
conditions found in the wild. Mucosomes as predictors of Bsal susceptibility could be used as a
crude first step in identifying highly susceptible species or resistant species without the use of
infection trials. This method could be of particular importance with endangered species,
where sacrificing animals for an infection trail is not possible.
Salamander skin mucosome effect on Bsal
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Our study is the first to investigate skin defenses of urodelans against the recently emerged
pathogen Bsal. We find that skin defenses could play a role in protecting salamanders from
this pathogen, which represents an important step towards understanding species variation in
disease susceptibly. As the introduction of Bsal poses a great risk to native salamander commu-
nities, increased knowledge of susceptibility could aid in conservation efforts enabling more
focused and effective conservation strategies.
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